@article{7de12bfd239349d987d722b561a829dd,
title = "Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial",
abstract = "To assess the effect of an angiotensin receptor blocker (ARB) on serum potassium and the effect of a serum potassium change on renal outcomes in patients with type 2 diabetes and nephropathy.",
keywords = "Angiotensin II Type 1 Receptor Blockers, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Female, Humans, Losartan, Male, Middle Aged, Potassium",
author = "Y Miao and D Dobre and Heerspink, {H J Lambers} and Brenner, {B M} and Cooper, {M E} and Parving, {Hans-Henrik Dyring} and S Shahinfar and D Grobbee and {de Zeeuw}, D",
year = "2011",
doi = "10.1007/s00125-010-1922-6",
language = "English",
volume = "54",
pages = "44--50",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "1",
}